Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Bristol-Myers Enters Into Immuno-Oncology Collaboration with Ono Pharmaceutical
July 25, 2014
Bristol-Myers Squibb and Ono Pharmaceutical have entered into a strategic agreement to jointly develop and commercialize multiple immunotherapies as single agents and combination regimens for cancer patients in Japan, South Korea and Taiwan.
Pharmaceutical Business Review
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing